New research confirms strong immunity to the vaccine, says Nuxville, Ten-Moder and Inc. I urge US and European regulators to allow COVID-19 to be used immediately.
To eradicate the cholera virus, many vaccine candidates must be successful in the world.
Our COVID-19 vaccine was introduced in We have just announced the initial effectiveness analysis for the Phase 3 COVE study for mRNA-1273 and today we plan to apply for a US FDA emergency use permit and conditional approval from the EMA. Read more https://t.co/90FbcVHdWN pic.twitter.com/36tpY0QeFl
– Smart (@moderna_tx) November 30, 2020
Modde is launching a vaccine in the United States in December, behind only Pipiter and German partner Biotech.
Massachusetts announced new results Monday.
In a large US study so far, 11 out of 196 COVID-19 cases were reported to be real test participants.
30 people became very sick, and they all got a place in Plasma.